|
|
Volumn 26, Issue 1, 1996, Pages 435-446
|
|
Cyclooxygenase 1 and 2 in rheumatic disease: Implications for nonsteroidal anti-inflammatory drug therapy
|
|
Author keywords
COX1 and COX2; efficacy; NSAID; safety
|
|
Indexed keywords
1 (4 FLUOROPHENYL) 2 [(4 METHYLSULFONYL)PHENYL]CYCLOPENTENE;
4 (3,5 DI TERT BUTYL 4 HYDROXYPHENYL) 2 METHYL 1,2 OXAZIN 3 ONE;
5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE;
6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE;
ACEMETACIN;
DICLOFENAC;
ETODOLAC;
FENCLOFENAC;
FLOSULIDE;
IBUPROFEN;
INDOMETACIN;
ISOENZYME;
MECLOFENAMIC ACID;
MEFENAMIC ACID;
MELOXICAM;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NABUMETONE;
NAPROXEN;
NIFLUMIC ACID;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SULINDAC;
ANTIINFLAMMATORY ACTIVITY;
BLOOD TOXICITY;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG SPECIFICITY;
ENZYME BINDING;
ENZYME SPECIFICITY;
GASTROINTESTINAL TOXICITY;
HUMAN;
NEPHROTOXICITY;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS INHIBITION;
REVIEW;
RHEUMATOID ARTHRITIS;
|
|
EID: 0029813244
PISSN: 00490172
EISSN: None
Source Type: Journal
DOI: 10.1016/S0049-0172(96)80024-2 Document Type: Article |
|
Times cited : (76)
|
|
References (0)
|
